Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

NCT06484114 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
315
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Fractyl Health Inc.